Davis Polk partner David Bauer and counsel Samantha Lefland authored “Strategic considerations in life sciences partnering” in Financier Worldwide. In the article, the authors discuss partnering transactions in the life sciences space and the strategic considerations that are critical to facilitating successful collaboration between parties. They note that these partnerships are important in fueling innovation in pharmaceutical and biotechnology research and development.

Read the full article

Copy link to share post